Trials / Sponsors / Ohr Pharmaceutical Inc.
Ohr Pharmaceutical Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD Age-related Macular Degeneration | Phase 3 | 2016-04-12 |
| Withdrawn | Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degene Age-Related Macular Degeneration | Phase 2 | 2015-07-01 |
| Completed | Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion Retinal Vein Occlusion, Macular Edema | Phase 1 / Phase 2 | 2013-04-01 |
| Completed | Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Deg Neovascular Age Related Macular Degeneration | Phase 2 | 2012-11-01 |
| Unknown | Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia Anorexia, Cancer Cachexia | Phase 2 | 2010-09-01 |